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Pre-clinical markers of Parkinson’s Disease (PD) are needed, and to be relevant in pre-clin-
ical disease, they should be quantifiably abnormal in early disease as well. Handwriting is
impaired early in PD and can be evaluated using computerized analysis of drawn spirals,
capturing kinematic, dynamic, and spatial abnormalities and calculating indices that quan-
tify motor performance and disability. Digitized spiral drawing correlates with motor scores
and may be more sensitive in detecting early changes than subjective ratings. However,
whether changes in spiral drawing are abnormal compared with controls and whether
changes are detected in early PD are unknown.
Methods
138 PD subjects (50 with early PD) and 150 controls drew spirals on a digitizing tablet, gen-
erating x, y, z (pressure) data-coordinates and time. Derived indices corresponded to over-
all spiral execution (severity), shape and kinematic irregularity (second order smoothness,
first order zero-crossing), tightness, mean speed and variability of spiral width. Linear
mixed effect adjusted models comparing these indices and cross-validation were per-
formed. Receiver operating characteristic analysis was applied to examine discriminative
validity of combined indices.
Results
All indices were significantly different between PD cases and controls, except for zero-
crossing. A model using all indices had high discriminative validity (sensitivity = 0.86, speci-
ficity = 0.81). Discriminative validity was maintained in patients with early PD.
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Conclusion
Spiral analysis accurately discriminates subjects with PD and early PD from controls sup-
porting a role as a promising quantitative biomarker. Further assessment is needed to
determine whether spiral changes are PD specific compared with other disorders and if
present in pre-clinical PD.
Introduction
A discrete pre-clinical phase for Parkinson's disease (PD), characterized by early motor
changes and non-motor manifestations, precedes the onset of diagnosable disease[1]. Identifi-
cation of high-risk individuals, near the cusp of overt clinical PD, is important as it will pro-
mote better understanding of the disease pre-clinical evolution. Approaches to pre-clinical
identificationmay facilitate enrollment of individuals at high risk for clinical PD and provide
criteria for the enrollment of preventive intervention studies. Such measures may also provide
objective, quantitative indices of motor decline, facilitating the conduct of secondary PD pre-
vention studies[2]. While motor and non-motor biomarkers to detect at-risk individuals have
been proposed, because PD is a motor disorder, very sensitive motor assessments are needed to
assess the transition into clinical disease. Prior to assessing their utility in pre-clinical PD, such
markers must first be validated to discern established PD from controls.
Motor rating scales, such as the Unified Parkinson’s Disease Rating Scalemotor subscale[3]
(UPDRS-III), the most widely used and accepted rating scale in PD, reflect symptom specific
motor dysfunction and correlate with underlying neuropathology and treatment interventions.
While easily performed, rating scales are examiner-dependent and relatively insensitive to sub-
tle early disease[4]. Available methods to objectively assess human tremor and upper limb bra-
dykinesia include accelerometer and gyroscopic systems[5, 6], electromagnetic or laser systems
[7], the Purdue Pegboard[8], finger tapping[9] and digitizing tablets[10, 11]. The present study
uses a digitizing tablet to facilitate computerized spiral analysis. This method quantifies upper
limb motor function from hand drawn spirals using a digitizing tablet and writing pen con-
nected to a computer. This method records the pen x and y positions, force and time data,
without wires or other attachments. It has been used to evaluate many different types of neuro-
logical disorders (see review[12]) including multiple sclerosis[11], PD motor symptoms[13],
essential tremor[14] and Niemann-Pick Disease[15]. Spiral degree of severity (DoS) has been
validated with total motor UPDRS scores and correlates with disease severity[13].
However, depending on its specificity for disease, there is the potential that it could be cap-
turing a late effect that is not abnormal in all PD subjects, and/or may be absent in early dis-
ease. Herein we extend the potential utility of spiral analysis in demonstrating that it has the
capacity to distinguish established PD from controls, including early PD subjects, and thus
warrants further assessment as a pre-clinical marker.
Methods
Subject selection and clinical ratings
PD subjects were recruited from parent studies of Biomarkers of PD at Mount Sinai Beth Israel
Medical Center. A diagnostic checklist was completed and only those meeting strict PD diag-
nostic criteria[16] were included. Subjects were rated using the UPDRS by movement disorders
neurologists and blinded to spiral performance. Unrelated unaffected control subjects were
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recruited from the pool of patient spouses visiting the movement disorders center of Columbia
University Medical Center and BIMC, and through individuals enrolled in the Einstein Aging
Study at the Albert Einstein College of Medicine. Controls were included if their age was
between 40–89 years old and had no history of neurologic disorders, upper limb injuries, vision
problems, or medication use for which tremor is a known side effect, and no history of rest or
action tremor. The study was approved by the Institutional ReviewBoards (IRB) of Columbia
University, Albert Einstein College of Medicine and BIMC and all participants gave informed
written consent. Participating subjects completed a questionnaire that recorded demographic
information as well as handedness, past medical history, and medication usage.
Computerized spiral analysis
Subjects were asked to draw ten Archimedean spirals with each hand inside a 10x10 cm square
on 8.5x11 inch letter-size paper, using a wireless, inked writing pen on a 9x12 inch digitizing
graphics tablet (Intuos 4, Wacom technology, Vancouver, WA) connected via standard USB to
a computer using proprietary software written in Objective-C (Fig 1). The tablet had a resolu-
tion of 1,000 points/cm (2,540 points/inch), an accuracy of 0.025 cm (0.01 inches), and 256 lev-
els of measurable pressure. Data were acquired at approximately 100 Hz. Subjects were shown
an example spiral and were allowed to practice before spiral collection.All subjects used the
same set-up, and were given the same instructions to sit with their shoulders parallel to the
front edge of the tablet, not let the arms rest on the tablet, and draw spirals from the center out-
ward. They were allowed to draw freely, to the extent that there were no constraints,
Fig 1. Digitized spiral analysis equipment and radius-angle transformation in spiral analysis. Digitized spiral analysis equipment (left) and radius-
angle transformations from an ideal spiral (top row) and a PD patient (bottom row). The radius-angle transformation is the mathematical equivalent of
“unraveling” the spiral such that the original two-dimensional graphic features, represented by (x, y) coordinates, are maintained with fidelity and
expressed linearly in terms of (r, θ) coordinates. The example black dot shown is three full cycles (6 π radians) into each of the spiral drawings. In
comparison to the ideal spiral straight transform, note the varying and irregular relationship between the radius and drawing cycles in the PD spiral.
doi:10.1371/journal.pone.0162799.g001
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attachments, or traceable templates, and they were asked to neither anchor nor rotate their
drawing hand so that collectionwas standardized across all participants. The duration of test
for training and the total of twenty spirals was approximately 20 minutes per subject. For those
PD subjects on antiparkinsonian treatment, spirals were performed in the “on” medication
state.
Data collected in the x, y, and z (pressure) axes and time provided virtual tri-axial record-
ings of spiral kinematics and dynamics. Features of spiral execution were expressed as mathe-
matical indices using Matlab (The MathWorks, Natick, MA), as previously described[11].
Quantification of the spirals was based on radius-angle transformations of the two-dimen-
sional spiral drawings which allowed for further computations of spiral analysis indices (S1
Material).
A matrix of 75 indices related to spiral execution including shape, loop tightness, tremors,
speed and writing dynamics was calculated from the transformations. For this study, we inves-
tigated a subset of indices found clinically relevant in PD: overall DoS spiral execution,mea-
sures of shape and kinematics based on second order smoothness (2ndSm) and first order
zero-crossing (1stZC), tightness (T), mean drawing speed (mSp) and a variability of loop-to-
loop spiral width index (SWVI).
DoS was a unitless composite index that measured overall spiral execution and spatial irreg-
ularity[11], and correlates with worsening of total UPDRS motor scores [13]. It was designed
as a computerized equivalent to the standard five-point clinical rating scale (0 to 4) of hand-
written spirals where 0 to 1 = normal, 1 to 2 = mild, 2 to 3 = moderate, and 3 to 4 = severely
abnormal. 2ndSm was a measure of spiral shape and curvature, defined as the derivative of
how close the linear transformation of the spiral remained to its own mean[11]. It quantifies
variation from ideal spiral shape. 1stZCmeasured how frequently the linear transform crossed
its own mean. More frequent crossing indicated greater irregularity. Compared with 2ndSm,
1stZC was more sensitive to small or frequent drawing fluctuations. Both 2ndSm and 1stZC
are unitless and mathematically describe spiral irregularity.
T (loops/cm)was the normalized number of turns of the spirals drawn over its total angular
change within a 10x10 cm square. T was the correlate of clinical micrographia, and calculated
as the average distance between consecutive spiral loops over all angles (in radians) divided by
the maximum spiral radius (in cm). mSP (cm/sec) was calculated as the distance between all
consecutive x, y points, averaged over the length of the spiral, divided by the average time
between points. SWVI was a unitless kinematic measure of loop-to-loop spiral width variation
with the oscillations of tremor removed, and is a correlate of ataxia[14]. Width variation high-
lights the fluctuations in spiral execution seen in patients with ataxia or erratic drawing (i.e.,
greater variability around an ideal trajectory). It is calculated as the coefficient of variation
(ratio of the standard deviation to the mean) of the medians of spiral widths per angle over the
entire 360° of each spiral loop. In addition, the variability between both hands (defined as the
absolute value of the difference between dominant and non-dominant hand indices) was
studied.
Statistical methods
Analyses were conducted using the Statistical Analysis System SAS version 9.1 (SAS Institute,
Cary, NC) and STATA12 (StataCorp, College Station, TX).Means and frequencies of demo-
graphic variables, UPDRS-III and spiral indices are described in Table 1. Exploratory univari-
ate differences in the spiral indices between cases and controls and differences between
dominant and non-dominant hand were analyzed using 2-tailed Student t-test, one-way
ANOVA or non-parametric equivalent when appropriate. Linear mixed effectmodels
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adjusting for age, gender and handedness were used to compare the different indices between
cases and controls. Models were performed including and excluding spiral severity. Receiver
operating characteristic analysis using logistic models was applied to examine the discrimina-
tive ability of the combined indices. To assess the potential for over-fitting the model to the
data, we used a three-fold, cross-validation study in which the data were randomly partitioned
into three subsamples. The model was trained on two of the subsamples and validated using
the remainder subsample. This was repeated three times. A separate analysis was performed in
the subset of early PD (duration of5 years).
Results
138 subjects with PD and 150 unaffected controls were included in the study, including 50 PD
subjects with disease duration of5 years. Demographic and disease characteristics are
described in Table 1. Groups did not differ for age and handedness; the male:female ratio was
75:63 among PD and 59:91 in controls. In the univariate analysis, all spiral indices except
1stZC were significantly different between cases and controls (Table 2, Fig 2). DoS in PD




DoS 0.74±0.34 1.45±0.45 <0.001
2ndSm -4.85±1.35 -4.32±1.60 0.002
1stZC 6.72±2.38 6.80±2.56 0.790
mSp 21.69±8.55 18.63±12.71 0.018
T 1.12±0.25 1.47±0.63 <0.001
SWVI* 0.26 (0.07) 0.33 (0.13) <0.001
Dominant–Non-dominant difference*
DoS 0.25 (0.27) 0.37 (0.45) 0.020
2ndSm 0.77 (0.83) 0.93 (1.38) 0.006
1stZC 0.85 (1.20) 0.98 (1.36) 0.360
mSp 2.70 (3.50) 2.61 (4.47) 0.416
T 0.15 (0.18) 0.21 (0.30) <0.001
SWVI 0.03 (0.05) 0.06 (0.08) <0.001
*Median and IQR are presented. Mann-Whitney’s test was used for comparison.
doi:10.1371/journal.pone.0162799.t002
Table 1. Demographic characteristics.
Control Subjects IPD P-value
Age (years, mean±SD, range) 64.25±14.26 (40–94) 65.12±10.40 (34–88) 0.55
Gender (n,% Female) 91 (61%) 63 (46%) 0.01
Handedness (n, % Right-handed) 129 (86%) 118 (86%) 0.90
Age at PD onset (years, mean±SD) — 58.50±10.90 —
PD duration (years, mean±SD) — 7.25±4.73 —
% Subjects on L-dopa (n,%) — 64 (46%) —
L-dopa dose (median, IQR) — 400 (200) —
Most affected side (n, % Right side) — 40 (28.78) —
Total UPDRS-III (median, IQR) — 13 (15) —
doi:10.1371/journal.pone.0162799.t001
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subjects was notably worse than controls (1.45 ± 0.45 vs. 0.74 ± 0.34, p<0.001). PD spirals had
larger magnitude 2ndSm (-4.32 ± 1.60 vs. -4.85 ± 1.35, p = 0.002); PD spirals were performed
slower (mSp 18.63 ± 12.71 vs. 21.69 ± 8.55 cm/s, p = 0.018) and were generally tighter (1.47 ±
0.63 vs. 1.12 ± 0.25, p<0.001). The median SWVI for the dominant-hand was also higher in PD
than control subjects (0.33 vs. 0.26, p<0.001). The variability between both hands was signifi-
cantly greater among cases for DoS, 2ndSm, T and SWVI.
PD subjects were classified according to motor subtypes into tremor-dominant (TD), inter-
mediate or postural instability-gait disorder (PIGD) groups based on UPDRS-III scores[17].
Spiral indices did not vary according to motor subtype with the exception of SWVI, which was
significantly higher in the PIGD group when compared to TD group (TD vs. PIGD p = 0.007).
A model using all the indices, including indices from both hands as well as variation
between hands, had good classification accuracy in discriminating PD from unaffected control
subjects (AUC = 0.875). The sensitivity and specificity from the optimal cut based on the You-
den index were calculated at 0.860 and 0.812, respectively. In a cross-validation study, we
divided the sample into three groups and examined the discriminative validity of cut-scores
derived from two thirds of the sample on the remaining third for all possible combinations.
The accuracy remained good from a three-fold cross-validation study (AUCs obtained were
0.845, 0.858 and 0.808, AUCaverage = 0.837), which confirmed that these spiral indices are
Fig 2. Spiral analysis indices in PD and controls. *p<0.05, mean spiral values presented except for SWVI (median).
doi:10.1371/journal.pone.0162799.g002
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valuable markers in separating PD from controls. To assess the ability of spiral in distinguish-
ing early PD (defined as disease duration either5 years) from controls, we also performed
ROC analysis restricted to early PD and controls and found that using spiral indices yielded
good accuracy in diagnosing early PD from cross-validation studies (disease duration5
years: AUCaverage = 0.816; duration4 years: AUCaverage = 0.812).
Discussion
Objective and reproducible metrics are neededwhen assessing subtle motor deficits in PD for
accurate clinical evaluations and therapeutic interventions. There are still no good early PD
biomarkers of motor function that are reliable and easy to obtain. To our knowledge, this is the
largest study to date of upper limb motor control evaluating spiral drawing in PD. We found
that spiral indices evaluating overall DoS, mSp, T, smoothness, and loop variability were signif-
icantly different between PD and controls (Table 2). These indices have been previously evalu-
ated in PD and other movement disorders[13, 14]. In particular, in PD spirals, mSp was lower
than in controls, and second-order smoothness, T and SWVI were also abnormal. Thus, PD
spirals were tighter, performedmore slowly and more irregularly than those drawn by controls.
This is partly in concordance to previous studies. In one that utilized an optoelectronic system
to quantitatively measure spiral executionmotor features, spatial organization, size and regu-
larity in PD subjects in the “on” medication state was very similar to that of controls, although
their PD spirals were slower[18]. In another using a digitizing tablet, PD subjects drew spirals
more slowly and were micrographic compared to normal controls[19].
Evaluation on PD subjects who were taking dopaminergicmedications was performed in
the parkinsonian “on” medication state. The decision to include only “on” medication spirals
was to stress the potential of this technique to discern betweenmilder forms of PD and con-
trols, as treated PD subjects may closely resemble controls. Indeed, discriminationwas present
both in early PD and in the “on” state.
As PD usually manifests asymmetrically, a challenge for any motoric test involving the
limbs in PD focuses on whether to capitalize on asymmetry and utilize data obtained from
side-to-side differences, or to use the average of both sides. To capture subtle differences
between dominant and non-dominant sides, which we would anticipate in early PD motor
markers[20], we studied side-to-side variability between hands. This was defined as the abso-
lute value of the difference between dominant and non-dominant hand indices. Similar differ-
ences are measured by the UPDRS-III[21], and may be consistent with the reported side of
symptom onset[20]. We found significantly greater differences in the dominant non-dominant
subtraction in all spiral indices except for 1stZC and mSp (Table 2). One possible explanation
for the absence of mSp differences in a PD subject would be if the dominant, typically faster
side, were affected first[21]. As there is an affinity for unilateral PD symptoms to occurmost
commonly in the dominant hand[20–22], there would be smaller differences between domi-
nant and non-dominant mSp if the dominant side becomes slower first. An alternate explana-
tion would be that by the time these PD subjects were evaluated, mSp may have decreased on
both sides approximately by the same degree. As expected, the majority of our subjects
reported right-hand dominance. 67% of PD subjects had asymmetric symptoms on their exam-
ination, defined as2 UPDRS-III point difference between right and left sides[20]; however,
only 32% of PD subjects had predominant symptoms on their dominant side vs. 34% in their
non-dominant side and 34% had symmetric disease as defined (p = 0.40). Spiral indices were
not significantly different between those with greater symptoms affecting the dominant vs.
non-dominant sides with the exception of 2ndSm, which was greater in those individuals with
worse symptoms affecting their non-dominant side (-4.74 vs. -4.00, p = 0.015). Dominant–
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non-dominant differences were significant only for degree of DoS and for 2ndSm. The differ-
ence in DoS and 2ndSm between dominant and non-dominant side were, perhaps as expected,
also greater for those with worse symptoms affecting their non-dominant side (difference in
DoS: 0.30 vs. 0.50, p = 0.001; difference in 2ndSm: 1.01 vs. 1.57, p = 0.02).
Motor subtype analysis into TD, intermediate and PIGD, showed that digitized spiral analy-
sis had the capacity to discriminate between PD and controls in all motor subtypes, including
non-TD PD, highlighting the sensitivity of the test to upper extremity bradykinesia and rigid-
ity, in addition to its more traditional ability to detect tremor[10].
Multiple methods have been proposed to objectively assess and quantify upper extremity
motor control in PD. Rating scales are widely accepted and used clinically such as the UPDRS
[3]. Such scales reflect symptom specificmotor dysfunction and correlate with underlying neu-
ropathology and therapeutic interventions[23], and in some instances have been applied to
mass screenings of parkinsonism[24]. Clinical rating scales, however, are examiner-dependent,
insensitive to subtle disease and less reliable when administered by non-neurologists[4, 25].
The Purdue Pegboard is a simple, relatively inexpensive apparatus that has good test-retest reli-
ability[8]. Finger tapping represents a simple task to quantitatively measure a motor deficit,
and has been utilized to evaluate medication response in PD[26]. However, both Purdue Peg-
board and finger tapping typically reflect speed and amplitude of movement without consider-
ation for tremor, and finger tapping only addresses fine motor control of the hand without
consideration of the proximal arm.
Digitized spiral analysis as presented in this study may provide advantages compared to
other proposedmethods. A portable wireless motion sensor device, Kinesia (ClevelandMedical
Devices Inc., Cleveland, OH) provides quantitative motor scores, and correlates to clinical rat-
ing scales[27, 28]. However, the set guidedmotor, tremor and bradykinesia tasks as well as the
wearable hardware may limit the free movement of the hand. A similar version of digitized spi-
ral analysis evaluated tremor intensity changes before and after ethanol ingestion in subjects
with alcohol-responsive essential tremor, and showed adequate validity, reliability and sensitiv-
ity to reflect such changes[29]. The subjects drew spirals between lines, forcing spatial consis-
tency across different spirals and might have restricted speed and other kinematic measures.
The type of upper limb motoric assessment presented in our study is safe, inexpensive, rela-
tively fast to perform, non-invasive, and does not require the use of wires or other attachments
that may limit upper limit movement. Information regarding time, pressure, and much more
carefully quantified data is available with a digitizing tablet than with, for example, measure-
ment of 2-D pen and paper spirals without other quantification. Spiral analysis may have even
better predictive capacity when combined with one of these other methods, or in combination
with gait or lower leg assessment.
Subtle writing changes may occur early in the course of PD and limit activities. This was
noted even in the early 19th century when statesman and educational reformer, von Humboldt,
recorded his small writing in a letter in 1823, and it was not until 1828 that he noted hand
tremor and difficultywith repetitive movements[30]. For individuals who suffer from concom-
itant memory loss, difficultywith writing impedes a useful technique for reminding and writ-
ing things down. Therefore, there is both clinical relevance but ecologic utility in evaluating
spiral analysis.
There are some limitations to our study. Spiral analysis with the digitizing tablet is a neuro-
physiological and psychophysical test with a critical need for the proper conditions and set-up,
so collectionmay be problematic for unsupervisedhome use.While the instructions were lim-
ited, all data were collected by an examiner who started and stopped the task, and directed the
subject to the next spiral. Although digitized spirals are easily and quickly collected in the clini-
cal setting, analysis is off-line and requires technical sophistication and competence. Also,
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quantitative motor measurements are limited to the upper extremity. Nevertheless, PD com-
monly affects the upper limb and an important amount of disability is derived from arm/hand
dysfunction. Advantages of this technique are that the subject freely draws spirals without
attachments, wires or the restrictions involved when tracing. Also, both distal and proximal
armmovements are involved, facilitating study of the entire upper limb, and not just the hand.
Evaluations in the "on" and "off "state to determine the effect of levodopa on spiral indices are
of interest and currently underway. Recruitment of opposite sex spouses poses the limitation of
gender disbalance between cases and controls. However, men and women do not differ in spi-
ral performance,[31] and we performed a sensitivity analysis limited men alone (S1 Table), we
found the same direction and significance of results. Finally, while it has been demonstrated
that spiral analysis separates controls from other disorders[14, 29], no direct comparisons were
performed between PD and other tremor disorders, and further study comparing essential
tremor and PD-mimics to PD is warranted.
Together with others studies demonstrating that digitized spiral analysis detects changes in
the unaffected side that were not clinically measurable by the UPDRS-III in very early and uni-
lateral PD, and can distinguish early PD from controls, suggests that digitized spiral analysis
warrants further evaluation as a potential marker to detect PD at its earliest, pre-clinical stages.
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